Current therapies linked to destruction of insulin-secreting cells that regulate blood sugar
Patients with a rare, genetic form of diabetes often are misdiagnosed as having type 2 diabetes because the two share symptoms.
In the pancreas, the beta cells (green, with blue nucleus) secrete insulin, but in the genetic form of diabetes called MODY1, those cells are under stress. Standard therapies are designed to make the beta cells secrete more insulin, but new research indicates that the drugs also increase stress levels in the cells, eventually killing beta cells and requiring patients to inject insulin.
Credit: Mills laboratory
But new research at Washington University School of Medicine in St. Louis suggests that treating such patients with therapies designed for type 2 diabetes is potentially harmful and that treatment guidelines need to change.
The underlying problems in patients with the genetic form of the disease -- called maturity-onset diabetes of the young (MODY1) -- are very different from those in type 2 diabetes. And treating MODY1 patients with drugs for type 2 diabetes appears to lead to destruction of insulin-secreting beta cells that regulate blood sugar, the scientists found.
The findings are published March 18, 2016 in The Journal of Biological Chemistry.
"People diagnosed with type 2 diabetes are treated with oral medications that make insulin-secreting beta cells very active," said first author Benjamin D. Moore, PhD, a former postdoctoral fellow at Washington University who is now at Massachusetts General Hospital. "But the MODY1 pathway we've uncovered shows that stimulating those cells with those drugs can lead to beta cell death. That means these patients can become dependent on insulin injections much sooner."
Moore said it's common for patients with MODY1-- who make up 3 to 5 percent of all patients with diabetes -- to transition from oral medications to insulin injections within 10 years of diagnosis as a way to keep their blood sugar in check. The new research suggests, however, that revving up the beta cells with oral medications increases cellular stress levels and eventually kills those cells, thus precipitating the need to switch to insulin.
Instead, patients with MODY1 might benefit from therapies that target a specific pathway that appears to be essential to the function of insulin-secreting cells. The researchers noted a relationship between a pair of proteins that regulate cells that secrete insulin and enzymes in the stomach, liver, kidney and intestines. One of those proteins is made by the gene that's altered in patients who have MODY1 diabetes.
Working with Jason C. Mills, MD, PhD, an associate professor of medicine at Washington University, Moore originally was studying cells in the stomach when he identified the insulin-secretion pathway disrupted in the genetic form of diabetes.
Mills and Moore believe the pathway they've identified in MODY1 also may be important in disorders that involve cells that secrete other enzymes.
"Nature doesn't re-invent the wheel," Mills said. "What these different cells secrete is very different, but the machinery is very similar. As with auto plants, although a BMW is very different from a Volkswagen, the factories where those cars are built are not really that different. It appears the same thing may be true for a number of these cells that secrete key enzymes in the gastrointestinal tract."
Mills' laboratory is continuing to conduct experiments to determine whether the same pathways are active in different types of secretory cells. Meanwhile, they believe doctors treating patients with diabetes need to determine whether they have the MODY1 form of the disorder before moving ahead with treatment.
"It's important to diagnose patients as accurately as possible and to attempt to target the correct pathway," Moore said.
Funding for this research comes from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), grant numbers DK094989. DK052574, DK087873 and P30 DK020579.
Moore BD, Jin FU, Lo H, Jung M, Wang H, Battle MA, Wollheim CB, Urano F, Mills JC. Transcriptional regulation of X-Box Binding Protein One (XBP1) by Hepatocyte Nuclear Factor 4a (HNF4a) is vital to beta-cell function. The Journal of Biological Chemistry. Published March 18, 2016.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Jim Dryden | EurekAlert!
The genes are not to blame
20.07.2018 | Technische Universität München
Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences